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Plasma Lecithin/Cholesterol Acyltransferase (LCAT) Activity in 
Multiple-Organ Donors: A Predictor of Allograft Viability in Clinical 
Liver Transplantation 
H. Higashi, K. Yanaga, M. Shimada, L. Makowka, D.H. Van Thiel, and T.E. Starzl 
THE purpose of this study was to evaluate the efficacy 
of plasma lecithin/cholesterol acyltransferase (LCAT) 
activity of multi-organ donors as a predictor of hepatic 
allograft viability prior to liver transplantation. 
MATERIALS AND METHODS 
Thirty-nine brain-dead donors were studied during a 5-month 
period between April and August 1988. The age of the donors 
ranged from 12 to 42 years (mean 24.1 years); 26 were male 
(66.7%). The causes of brain death among the donors consisted of 
closed head irijury in 21 (53.8%), gun-shot in 9 (23.1%), subarach-
noid hemorrhage in 5 (12.8%), and others in 4 donors (10.3%). The 
allografts were stored cold (4°C) in University of Wisconsin 
solution. 
Early post-transplant allograft function in the recipients was 
classified into three groups: good, fair, and poor function, accord-
ing to the highest SOOT, SOPT and prothrombin time (PT) within 
5 days following liver transplantation (good: SOOT ~ 1500 U/L, 
SOPT ~ 1000 UIL, PT ~ 20.0 seconds; fair: SOOT ~ 3500, SOPT 
~ 2500, PT ~ 20.0 seconds; poor: SOOT> 3500, SOPT > 2500, 
PT > 20.0 seconds). Orafts were put into the lowest (poorest) 
category into which any of the assessment value fell. Blood 
samples from the donors were drawn immediately prior to the 
aortic crossclamp. 
Plasma LCAT activity was determined using a LCA T test kit-S 
(Nippon Shoji Co., Osaka Japan) at 37°C with a modification of 
the method described by Nagasaki and Akanuma. I A unit of 
LCAT activity was expressed as an ability to esterify the free 
cholesterol at 37°C (p.g/mLIh) in the assay mixture. LCAT activ-
ities of the plasma from 5 healthy male volunteers were 31.0 ± 5.7 
U. 
RESULTS 
Figure 1 demonstrates the correlation between the donor 
plasma LCAT activity and early post-transplant allograft 
function. The LCAT activity was significantly higher in the 
donors with good allograft function than in ones with fair 
or poor function (P < 0.05). 
Among the donor variables evaluated (age, duration of 
hospital stay, SOOT, SOPT, total bilirubin, PT, and graft 
ischemic time), the age ofthe donors with fair function was 
significantly higher and the duration of hospital stay was 
significantly longer than those of ones with good function 
(P < 0.05). Other variables exhibited no correlation with 
early allograft function. 
Among the clinical variables of the recipients (age, 
SOOT, SOPT, total bilirubin, prothrombin time and intra-
operative blood loss), the intra-operative blood loss of the 
recipients who received graft with poor function was 
smaller than that of the ones with good function. 
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Fig 1. Correlation between the plasma LCAT activity in mUlti-
organ donors and early post-transplant allograft function (LCAT = 
lecithin/cholesterol acyltransferase; U = lL9/mUh). 
DISCUSSION 
In 1987 Makowka et aJ2 reported that none of the currently 
available donor variables could predict the transplant 
outcome. In our study, plasma LCAT activity correlated 
with healthy hepatic allograft function. 
In the field of clinical liver transplantation, only a few 
studies have been reported on the assessment of the 
viability of hepatic allografts prior to liver transplantation. 
In 1988 Lanir et al3 and Kamiike et al4 reported that the 
adenine nucleotides level in hepatic allografts predicted 
the outcome ofliver transplantation. For the measurement 
of adenine nuc1eotides, however, the allograft needs to be 
biopsied after donor laparotomy in the operating room, 
and special equipment is required. In 1989 Oellerich et al5 
reported that serum levels of monoethylglycinexylidine 
after intravenous injection of I mg/Kg of lidocaine corre-
lated well with the viability of the hepatic allograft. Their 
technique requires the use of a special equipment for the 
determination of lidocaine metabolite. The plasma LCAT 
activity, on the other hand, can be measured easily with 
the use of a commercially available kit without special 
skills or equipment. 
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In summary, the determination of LCAT activity in 
multiple-organ donors seems to be a discriminating and 
practical predictor of hepatic allograft viability prior to 
liver transplantation. 
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